pet care
Elanco Pet Health Surge vs 2025 Plateau Exposes Gains
Elanco Pet Health Surge vs 2025 Plateau Exposes Gains Yes, Elanco’s newest therapeutic push lifted Q1 2026 earnings to $1.2 billion, surpassing the flat performance of 2025 and signaling a clear growth trajectory. The launch of a novel canine arthritis drug sparked higher veterinarian orders and boosted pet-owner